Skip to content

MSF calls for rapid registration of heat-stable Kaletra in low-income countries

Management of HIV and hepatitis B or C co-infection in resource-limited settings

Treatment interruption arm of DART study halted

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

CD8 T-cells only kill a fifth of the HIV-infected CD4 T-cells

Prevention alongside treatment only way to contain HIV epidemic, scientific modelling finds

Proteins can help cells protect themselves from infection with HIV

US launches drive to find better HIV treatments for children in poorest countries